lysylproline has been researched along with glycylproline in 2 studies
| Studies (lysylproline) | Trials (lysylproline) | Recent Studies (post-2010) (lysylproline) | Studies (glycylproline) | Trials (glycylproline) | Recent Studies (post-2010) (glycylproline) |
|---|---|---|---|---|---|
| 10 | 0 | 2 | 120 | 1 | 35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Z; Li, T; Lu, D; Qi, W; Su, R; Wu, S | 1 |
| Batra, Y; Jaglan, S; Kaur, B; Rani, S; Singh, P | 1 |
2 other study(ies) available for lysylproline and glycylproline
| Article | Year |
|---|---|
CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Anti-Infective Agents; Models, Molecular; Peptides; Quantitative Structure-Activity Relationship; Regression Analysis; Taste | 2014 |
Proline based rationally designed peptide esters against dipeptidyl peptidase-4: Highly potent anti-diabetic agents.
Topics: Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Drug Design; Esters; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Hypoglycemic Agents; Oligopeptides; Proline; Sitagliptin Phosphate | 2022 |